Unknown

Dataset Information

Challenges in mucosal HIV vaccine development: lessons from non-human primate models.


ABSTRACT: An efficacious HIV vaccine is urgently needed to curb the AIDS pandemic. The modest protection elicited in the phase III clinical vaccine trial in Thailand provided hope that this goal might be achieved. However, new approaches are necessary for further advances. As HIV is transmitted primarily across mucosal surfaces, development of immunity at these sites is critical, but few clinical vaccine trials have targeted these sites or assessed vaccine-elicited mucosal immune responses. Pre-clinical studies in non-human primate models have facilitated progress in mucosal vaccine development by evaluating candidate vaccine approaches, developing methodologies for collecting and assessing mucosal samples, and providing clues to immune correlates of protective immunity for further investigation. In

SUBMITTER: Tuero I 

PROVIDER: S-EPMC4147690 | biostudies-literature | 2014 Aug

REPOSITORIES: biostudies-literature